/ICUI
ICU Medical, Inc.
ICUI • NASDAQICUI • NASDAQ • Healthcare
$128.78-3.72%-4.98
$128.78-3.72%(-4.98)Healthcare
GoAI Score
Sign in to unlock
Valuation
50Fair Value
Sentiment
100Bullish
Risk
88Low Risk
Momentum
29Negative
Institutional-Grade Intelligence
🏆PRO
Actionable Intelligence
AI-driven stance, execution logic & risk thresholds
Catalyst Roadmap
Event timeline with expected impact & market context
Deep Insights
Fact-checked analysis & score logic breakdown
Financial Statements
Margin Trends
Gross
36.8%▲2.1pp
Revenue after COGS
Operating
4.8%▲3.0pp
After operating expenses
Net
0.0%▲5.0pp
Bottom-line profitability
Gross Margin
Operating Margin
Net Margin
Valuation Snapshot
P/E Ratio
4802.4
Price vs earnings
EV/EBITDA
14.1
Enterprise value
FCF Yield
2.6%
Cash generation
Earnings Yield
0.0%
Inverse of P/E
Capital Efficiency
0
GoAI Quality ScoreWeak
ROEReturn on Equity
0.0%Fair
ROAReturn on Assets
0.0%Fair
ROICReturn on Invested Capital
0.7%Fair
Financial Health
Current RatioHealthy
2.36
Short-term solvency (>1.5)
Net Debt / EBITDAHigh
3.32x
Debt repayment capacity (<3x)
Income QualityStrong
245.69
Cash backs earnings (>1)
Revenue & Profitability
Revenue
Net Income
Net Loss
Income Statement
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $2.23B | $2.38B | $2.26B | $2.28B | $1.32B |
| Gross Profit | $819.65M | $824.78M | $739.87M | $697.76M | $491.49M |
| Gross Margin | 36.8% | 34.6% | 32.8% | 30.6% | 37.3% |
| Operating Income | $106.95M | $42.96M | $22.82M | -$42.90M | $123.25M |
| Net Income | $732.00K | -$117.69M | -$29.66M | -$74.29M | $103.14M |
| Net Margin | 0.0% | -4.9% | -1.3% | -3.3% | 7.8% |
| EPS | $0.03 | -$4.83 | -$1.23 | -$3.11 | $4.86 |
Average Price Target
$179.00▲ 39.0% Upside
Past 12 Months
12 Month Forecast
Based on 50 Wall Street analysts offering 12 month price targets for ICU Medical, Inc., the average price target is $179.00, with a high forecast of $180.00 and a low forecast of $178.00. The average price target represents a 39.0% increase from the current price of $128.78.
Highest
$180.00
Average
$179.00
Lowest
$178.00
Rating Distribution
Strong Buy
1
9%
Buy
8
73%
Hold
2
18%
Sell
0
0%
Strong Sell
0
0%
Recent Analyst Ratings
FirmActionRatingDate
Keybanc● Maintain
Overweight
2026-02-20Piper Sandler● Maintain
Overweight
2026-02-20Keybanc● Maintain
Overweight
2025-11-07Piper Sandler● Maintain
Overweight
2025-11-07Keybanc● Maintain
Overweight
2025-10-21Piper Sandler● Maintain
Overweight
2025-09-10Raymond James● Maintain
Strong Buy
2025-08-08Raymond James● Maintain
Strong Buy
2025-05-09Keybanc● Maintain
Overweight
2025-04-21Needham● Maintain
Hold
2025-04-08Earnings History & Surprises
BEAT RATE
94%
Last 18 quarters
AVG SURPRISE
+23.7%
EPS vs Estimate
BEATS / MISSES
17/1
Last 18 quarters
LATEST EPS
$1.91
Q1 '26
QUARTERLY EPS TREND
Estimated
Beat
Miss
QUARTERLY DETAIL
Q1 '26
+13.0%
$1.91 vs $1.69
Q4 '25
+42.0%
$2.03 vs $1.43
Q3 '25
+45.8%
$2.10 vs $1.44
Q2 '25
+39.8%
$1.72 vs $1.23
Q1 '25
+42.6%
$2.11 vs $1.48
Q4 '24
+27.2%
$1.59 vs $1.25
Q3 '24
+59.2%
$1.56 vs $0.98
Q2 '24
+14.3%
$0.96 vs $0.84
Q1 '24
+33.1%
$1.57 vs $1.18
Q4 '23
+21.7%
$1.57 vs $1.29
Q3 '23
+21.3%
$1.88 vs $1.55
Q2 '23
+26.1%
$1.74 vs $1.38
No investor questions available.
Latest News
No news available